Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
(Peptide Sciences) Oncology & adjunctive therapy Interestingly, since senescent cells often accumulate in tissues post-chemotherapy and may contribute to relapse or fibrosis, FOXO4-DRI might serve as adjuncts in oncology (preclinical) by clearing therapy-induced senescent cells
Option 1: Discard and mix fresh Cost: Price of new vial Benefit: Guaranteed full potency Risk: None (besides cost) Option 2: Continue using Cost: None (already paid for) Benefit: Don't waste remaining peptide Risk: 10-15% potency loss means 10-15% less effectiveness Calculation: If vial costs $50 and you're at day 35 with half remaining, you're deciding whether to waste $25 to guarantee full potency, or accept 10-15% reduced effectiveness
The risk appears low and was not dose-dependent
They are chemically distinct: copper binding alters charge, conformation, and the chemistry researchers are usually probing, so the two are not interchangeable in experimental design
US$ 27.98
US$ 23.35
US$ 23.82
US$ 24.45
US$ 29.10
US$ 20.41
US$ 21.42
US$ 26.30
US$ 24.78
US$ 24.16
US$ 24.60
